News | July 28, 2015

FDA Approves The ReShape™ Integrated Dual Balloon System, a First-Of-Its-Kind Non-Surgical Weight Loss Procedure for People with Mild to Moderate Obesity – Next generation dual balloon designed to create a feeling of fullness while providing patient comfort and...

News | July 23, 2015

Chimerix Announces Positive Topline Results From Brincidofovir Pivotal Study in Animal Model for Smallpox Data Demonstrated Statistically Significant Survival Benefit DURHAM, N.C., July 23, 2015 (GLOBE NEWSWIRE) — Chimerix, Inc. (NASDAQ:CMRX), a...

News | July 22, 2015

QPID Health sequences the “digital DNA” in your health record Alvin Yu, MD, Clinical Content Engineer – July 22, 2015 – As an engineer turned physician who returned to engineering as a QPID clinical content engineer (yes, it’s confusing!), I’ve been...

News | July 8, 2015

Afferent Pharmaceuticals Raises $55 Million in Oversubscribed Crossover Financing – Funds to advance pipeline, and clinical lead AF-219 for the treatment of pathologic cough, including in idiopathic pulmonary fibrosis (IPF) patients – SAN MATEO,...

News | January 2, 2013

Relypsa Announces Agreement with FDA on Special Protocol Assessment for Patiromer Phase 3 Trial for the Treatment of Hyperkalemia According to data reported at Kidney Week 2012, an ongoing Phase 2b study of patiromer met the interim analysis primary endpoint of mean...
tristique consequat. efficitur. Praesent sit felis libero. ipsum Lorem id nunc commodo